SE0004053D0 - N-type calcium channel antagonists for the treatment of pain - Google Patents

N-type calcium channel antagonists for the treatment of pain

Info

Publication number
SE0004053D0
SE0004053D0 SE0004053A SE0004053A SE0004053D0 SE 0004053 D0 SE0004053 D0 SE 0004053D0 SE 0004053 A SE0004053 A SE 0004053A SE 0004053 A SE0004053 A SE 0004053A SE 0004053 D0 SE0004053 D0 SE 0004053D0
Authority
SE
Sweden
Prior art keywords
treatment
pain
calcium channel
type calcium
channel antagonists
Prior art date
Application number
SE0004053A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0004053A priority Critical patent/SE0004053D0/sv
Publication of SE0004053D0 publication Critical patent/SE0004053D0/sv
Priority to JP2002539345A priority patent/JP2004513125A/ja
Priority to EP01981239A priority patent/EP1339706B1/en
Priority to ES01981239T priority patent/ES2261496T3/es
Priority to US10/415,785 priority patent/US6815447B2/en
Priority to DE60118956T priority patent/DE60118956T2/de
Priority to PCT/SE2001/002388 priority patent/WO2002036586A1/en
Priority to AT01981239T priority patent/ATE323693T1/de
Priority to AU2002212894A priority patent/AU2002212894A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
SE0004053A 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain SE0004053D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain
JP2002539345A JP2004513125A (ja) 2000-11-06 2001-10-31 疼痛治療のためのｎ−型カルシウムチャンネル拮抗薬
EP01981239A EP1339706B1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
ES01981239T ES2261496T3 (es) 2000-11-06 2001-10-31 Antagonistas de los canales de calcio de tipo n para el tratamiento del dolor.
US10/415,785 US6815447B2 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
DE60118956T DE60118956T2 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
PCT/SE2001/002388 WO2002036586A1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
AT01981239T ATE323693T1 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
AU2002212894A AU2002212894A1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
SE0004053D0 true SE0004053D0 (sv) 2000-11-06

Family

ID=20281713

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Country Status (9)

Country Link
US (1) US6815447B2 (sv)
EP (1) EP1339706B1 (sv)
JP (1) JP2004513125A (sv)
AT (1) ATE323693T1 (sv)
AU (1) AU2002212894A1 (sv)
DE (1) DE60118956T2 (sv)
ES (1) ES2261496T3 (sv)
SE (1) SE0004053D0 (sv)
WO (1) WO2002036586A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
AU2003247425B2 (en) * 2002-05-22 2007-03-08 Amgen Inc. Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
PL376372A1 (en) * 2002-08-08 2005-12-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
ATE527250T1 (de) 2002-11-21 2011-10-15 Novartis Ag 2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
JP4691041B2 (ja) * 2003-11-20 2011-06-01 チルドレンズ ホスピタル メディカル センター Ｇｔｐアーゼ阻害剤および使用方法
US7301022B2 (en) 2005-02-15 2007-11-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
WO2006105670A1 (en) * 2005-04-08 2006-10-12 Neuromed Pharmaceuticals Ltd. Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
WO2007133481A2 (en) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
CN101711241A (zh) 2007-02-06 2010-05-19 诺瓦提斯公司 Pi3-激酶抑制剂和它们的使用方法
KR20130044381A (ko) * 2010-03-04 2013-05-02 머크 샤프 앤드 돔 코포레이션 카테콜 ｏ－메틸 트랜스퍼라제의 억제제 및 정신병적 장애의 치료에서의 그의 용도
RU2572624C2 (ru) 2010-03-04 2016-01-20 Мерк Шарп Энд Домэ Корп. Ингибиторы катехол-о-метилтрансферазы и их применение в лечении психических расстройств
BR112012021652A2 (pt) 2010-03-04 2016-06-21 Merck Sharp & Dohme composto, uso do mesmo, e, composição farmacêutica
WO2012122279A1 (en) 2011-03-08 2012-09-13 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
GEP20166432B (en) 2011-09-27 2016-02-10 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
WO2014141104A1 (en) 2013-03-14 2014-09-18 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794043A (en) 1955-06-03 1958-04-30 Ici Ltd New quinoline derivatives
SK14272000A3 (sk) 1998-03-26 2001-05-10 Japan Tobacco Inc. Antagonista nociceptínu, derivát amidu, farmaceutický prostriedok, spôsob, použitie a komerčné balenie

Also Published As

Publication number Publication date
JP2004513125A (ja) 2004-04-30
WO2002036586A1 (en) 2002-05-10
US6815447B2 (en) 2004-11-09
AU2002212894A1 (en) 2002-05-15
EP1339706B1 (en) 2006-04-19
ATE323693T1 (de) 2006-05-15
DE60118956D1 (de) 2006-05-24
EP1339706A1 (en) 2003-09-03
US20040058945A1 (en) 2004-03-25
ES2261496T3 (es) 2006-11-16
DE60118956T2 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9504661D0 (sv) New compounds
PT1157037E (pt) Conjugados de gcsf
NO20026064D0 (no) Nye forbindelser
PT1411908E (pt) Tratamento de infeccoes da unha com no
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
ATE233274T1 (de) Oxyiminopregnancarbolactone
SE9802729D0 (sv) Novel Compounds
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
CY1108808T1 (el) Ενωσεις μοτιλιδης
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9802208D0 (sv) Novel compounds
MY133969A (en) Indoloquinazolinones
EA200001039A1 (ru) Кальцилитические соединения
SE0003476D0 (sv) Compounds
SE0203070D0 (en) Novel compounds
SE0303280D0 (sv) Novel compounds
SE0203300D0 (sv) Novel Compounds
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DE60137534D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
SE0004055D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE0302755D0 (sv) Novel compounds
SE0102857D0 (sv) N-type calcium channel antagonists for the treatment of pain
MXPA03004111A (es) Composiciones de n-(1 -metiletilaminocarbonil)-4 -(3-metilfenilamino) -3-piridil-sulfonamida y oligosacaridos ciclicos con una mayor liberacion.